HOUSEHOLD CONTACT STUDY OF BORDETELLA-PERTUSSIS INFECTIONS

被引:148
作者
DEEN, JL
MINK, CM
CHERRY, JD
CHRISTENSON, PD
PINEDA, EF
LEWIS, K
BLUMBERG, DA
ROSS, LA
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90095
[2] UNIV CALIF LOS ANGELES,MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90095
[3] UNIV CALIF LOS ANGELES,CTR VACCINE RES,LOS ANGELES,CA 90095
[4] CHILDRENS HOSP LOS ANGELES,DEPT PEDIAT,LOS ANGELES,CA 90027
[5] ST LOUIS UNIV,SCH MED,CTR VACCINE DEV,ST LOUIS,MO
关键词
D O I
10.1093/clinids/21.5.1211
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Household contacts of primary pertussis cases were evaluated, Infection was determined by culture, direct fluorescent antibody assay, and serological criteria, Agglutinin titers and values of ELISA IgG and IgA antibodies to lymphocytosis-promoting factor, filamentous hemagglutinin, and pertactin were determined, In 39 households 255 subjects were exposed; 114 remained well (group 1), 53 had mild illness (group 2), and 88 had pertussis (group 3). The infection rates were 46% (group 1), 43% (group 2), and 80% (group 3). In a subgroup of subjects seen within 14-28 days of exposure, it was found that none with clinical pertussis had a value of IgG antibody to pertactin in acute-phase sera of greater than or equal to 50 ELISA units (EU) per mt or an agglutinin titer of >256. Of the primary cases, 53% were greater than or equal to 13 years of age. These data point out the importance of Bordetella pertussis infections in adolescents and adults as a source of infection in young children, Our subgroup data suggest that high values of antibody to pertactin and high agglutinin titers may be predictive of protection against clinical pertussis.
引用
收藏
页码:1211 / 1219
页数:9
相关论文
共 45 条
  • [1] CLONING, EXPRESSION, AND DNA-SEQUENCE ANALYSIS OF GENES ENCODING NONTYPABLE HAEMOPHILUS-INFLUENZAE HIGH-MOLECULAR-WEIGHT SURFACE-EXPOSED PROTEINS RELATED TO FILAMENTOUS HEMAGGLUTININ OF BORDETELLA-PERTUSSIS
    BARENKAMP, SJ
    LEININGER, E
    [J]. INFECTION AND IMMUNITY, 1992, 60 (04) : 1302 - 1313
  • [2] BEITER A, 1993, OBSTET GYNECOL, V82, P691
  • [3] BLUMBERG DA, 1990, DHHS FDA901162 PUBL
  • [4] SEROLOGICAL RESPONSE TO FILAMENTOUS HEMAGGLUTININ AND LYMPHOCYTOSIS-PROMOTING TOXIN OF BORDETELLA-PERTUSSIS
    BURSTYN, DG
    BARAFF, LJ
    PEPPLER, MS
    LEAKE, RD
    STGEME, J
    MANCLARK, CR
    [J]. INFECTION AND IMMUNITY, 1983, 41 (03) : 1150 - 1156
  • [5] CHERRY J D, 1988, Pediatrics, V81, P939
  • [6] COMPARISON OF VALUES OF ANTIBODY TO BORDETELLA-PERTUSSIS ANTIGENS IN YOUNG GERMAN AND AMERICAN MEN
    CHERRY, JD
    BEER, T
    CHARTRAND, SA
    DEVILLE, J
    BEER, E
    OLSEN, MA
    CHRISTENSON, PD
    MOORE, CV
    STEHR, K
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1271 - 1274
  • [7] PERTUSSIS IN NEONATES
    CHRISTIE, CDC
    BALTIMORE, RS
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (10): : 1199 - 1202
  • [8] UNRECOGNIZED PERTUSSIS INFECTION IN ADOLESCENTS
    CROMER, BA
    GOYDOS, J
    HACKELL, J
    MEZZATESTA, J
    DEKKER, C
    MORTIMER, EA
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (05): : 575 - 577
  • [9] FREQUENCY OF UNRECOGNIZED BORDETELLA-PERTUSSIS INFECTIONS IN ADULTS
    DEVILLE, JG
    CHERRY, JD
    CHRISTENSON, PD
    PINEDA, E
    LEACH, CT
    KUHLS, TL
    VIKER, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) : 639 - 642
  • [10] FEIGIN RD, 1992, TXB PEDIAT INFECT DI, V2, P1208